Consolidated net sales soared 193.4% to Rs 4.43 crore in Q3 December 2021 over Rs 1.51 crore in Q3 December 2020. Consolidated financial cost skid 7.14% to Rs 0.13 crore in Q3 FY22 as against Rs 0.14 crore in Q3 FY21. Total expenses grew 30% to Rs 38.26 crore in Q3 December 2021 as compared to Rs 29.43 crore in Q3 December 2020.
Shares of Suven Life Sciences lost 0.34% to end at Rs 89 on BSE. Suven Life Science is a biopharmaceutical company focused on discovering, developing, and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
